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Abstract: Two aerobic granular sludge (AGS) sequential batch reactors were operated at a mild (15 ◦C)
temperature for 180 days. One of those bioreactors was exposed to a mixture of diclofenac, naproxen,
trimethoprim, and carbamazepine. The AGS system, operating under pressure from emerging
contaminants, showed a decrease in COD, BOD5, and TN removal capacity, mainly observed during
the first 100 days, in comparison with the removal ratios detected in the control bioreactor. After an
acclimatisation period, the removal reached high-quality effluent for COD and TN, close to 95% and
90%, respectively. In the steady-state period, trimethoprim and diclofenac were successfully removed
with values around 50%, while carbamazepine and naproxen were more recalcitrant. The dominant
bacterial OTUs were affected by the presence of a mixture of pharmaceutical compounds, under
which the dominant phylotypes changed to OTUs classified among the Pseudomonas, Gemmobacter,
and Comamonadaceae. The RT-qPCR and qPCR results showed the deep effects of pharmaceutical
compounds on the number of copies of target genes. Statistical analyses allowed for linking the total
and active microbial communities with the physico-chemical performance, describing the effects
of pharmaceutical compounds in pollution degradation, as well as the successful adaptation of the
system to treat wastewater in the presence of toxic compounds.
Keywords: aerobic granular sludge; pharmaceutical compounds; wastewater; total microbial com-
munity; active microbial community; qPCR
1. Introduction
The worldwide concern about pharmaceutical compounds (PCs), which are named
“emerging contaminants”, has been growing during recent decades. The widespread
detection of pharmaceuticals in terrestrial and aquatic systems has engendered significant
scientific and regulatory concerns [1]. These products are widely used but bring harmful
effects to the environment. Most of the PCs are not completely degraded by human or
animal bodies, thus being discharged, by means of excretion, mostly unaltered or as an
active metabolite going into wastewater treatment plants (WWTPs), finally ending up
in water ecosystems. The PCs mainly reported in wastewaters include antibiotics, anti-
inflammatories, and antiepileptics, among others. Even at low concentrations, the PCs
could affect the composition of the microbial communities that comprise the secondary
treatment technology, and hence disturb the metabolic networks in the population [2].
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The most abundant pharmaceutical compounds analysed in wastewater from the biggest
hospital of the south of Spain, specifically in Granada, were carbamazepine, trimethoprim,
naproxen, and diclofenac, as described by Olicón-Hernandez et al. [3].
Carbamazepine (CBZ) is a highly recalcitrant habitual anticonvulsant drug. Currently,
it is used as an indicator of anthropogenic impacts on water bodies [4]. Trimethoprim (TMP)
is an antibiotic belonging to chemotherapeutic agents acting on dihydrofolate reductase,
inhibiting the synthesis of tetrahydrofolic acid, which is the most often-used veterinary
medicine [5]. TMP has been habitually detected in wastewater [6], demonstrating that
conventional wastewater treatment processes do not effectively remove it. The presence
of certain antibiotic concentrations in the natural environment, especially in water bodies,
causes adverse and damaging effects, including bacteria developing antibiotic resistant
genes [7]. Naproxen (NPX) is a commonly used drug that possesses anti-inflammatory
and analgesic activities, namely a pain killer, due to its ability to inhibit cyclooxygenase
enzymes that promote inflammation [8]. Diclofenac (DCF) is also a weak organic acid
that belongs to the group of non-steroidal anti-inflammatory drugs, which play an anti-
inflammatory and analgesic role, inhibiting the synthesis of prostaglandins [9]. The high
concentrations of NPX and DCF in natural water bodies could be caused by the polar
nature of both, and they easily escape the wastewater treatment process and are discharged
into the environment [10].
Aerobic granular sludge (AGS) technology has been extensively studied during recent
years because it is a system with several advantages in comparison with conventional
activated sludge (CAS). The aerobic granular sludge is a complex matrix of microorgan-
isms embedded in a complex of extracellular polymeric substances (EPSs) that act as a
union bridge, providing particles of self-immobilised microorganisms with no supporting
carrier [11]. The hydrodynamic circular motion promotes the formation of spherical sludge
aggregates, which allow the coexistence of aerobic, anoxic, and anaerobic layers, where
several metabolic pathways are carried out. The AGS technology has numerous advantages
in comparison with other biological treatment technologies, such as nutrient removal in
the same chamber under the same operational conditions, excellent settleability, resilience
to shocks against toxic compounds, high biomass retention, and low, or absence of, waste
biomass production [12,13]. Additionally, AGS has a high efficiency to remove, adsorb,
or transform other compounds such as particulate matter, pharmaceutical compounds,
nuclear waste, olive washing water, or textile wastewater, amongst others [11,14]. The
treatment of these industrial wastewaters, in which there are high loads of toxic com-
pounds, is possible due to the mass transfer limitations to protect the microorganisms in
the internal layers from shock loading with different compounds of differing natures [4].
In fact, the AGS technology has acquired relevance in wastewater treatment areas for
removing emerging contaminants. Finally, most studies about biological technologies
linking the operational conditions, physico-chemical determinations, and the microbial
communities understand that the contribution to some actions is strictly related to the
relative or absolute abundance in the population studied by target genes. However, the
study of metabolically active microorganisms makes a deep change in the conception of
the roles that microorganisms play in wastewater treatment. Consequently, there is a lack
of knowledge when the biological analysis is based exclusively on DNA analysis, while
that of RNA material is ignored. There are few studies that have identified and quantified
both of the nucleic acids in biological wastewater technologies, but, nevertheless, they are
very valuable [15,16].
Therefore, the main objective of this study is to evaluate the effect of a mixture of
pharmaceutical compounds on the physico-chemical performance and granular stability
(1); and on the total and metabolically active microbial community (2); and quantify the
removal capability for the selected emergent contaminant (3).
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2. Materials and Methods
2.1. Design of Bioreactors, Configuration, and Operation
Two AGS reactors were implemented using cylindrical columns with a height of 45 cm
and a diameter of 9 cm (Figure S1), operated as sequential batch reactors (SBRs). The
operational volume was 2.5 L, of which 60% was exchanged per cycle. The hydraulic
retention time was 6.6 h and the cycles consisted of: 33 min for feeding with raw water,
230 min of continuous aeration, 3 min of settling, and 4 min for effluent discard. The air
was introduced by fine bubbles at the bottom using a 3 L min−1 flow rate. The bioreactors
were kept at 15 ◦C during the 180 days of experimentation. The pH was monitored at a
value of 7.6 ± 0.2, and the dissolved oxygen was close to saturation.
Both bioreactors were firstly inoculated with 1 L of granular biomass from an aero-
bic granular sludge system operated in a sequential batch reactor for treating synthetic
wastewater at a lab scale [17]. The bioreactors were fed using synthetic wastewater, sim-
ulating urban sewage with the following composition: CH3COONa 0.9 g L−1, NH4Cl
0.25 g L−1, MgSO4·7H2O 0.1 g L−1, K2HPO4 0.085 g L−1, KCl 0.04 g L−1, and KH2PO4
0.03 g L−1 [18]. In every feeding period, wastewater was introduced from the top of the
reactors by peristaltic pumps (Watson Marlow, UK). Four pharmaceuticals (diclofenac,
naproxen, trimethoprim, and carbamazepine) were added to one of the two bioreactors
at a concentration of 25 µM [19]. The concentration of these drugs added in the influent,
expressed in mg L−1, were for diclofenac 7.403696 mg L−1, for naproxen 5.756449 mg L−1,
for trimethoprim 7.258 mg L−1, and for carbamazepine 5.906725 mg L−1. The other AGS
was used as a control without pharmaceutical compounds in order to evaluate their effect
on the physico-chemical performance, granular stability, and microbial community. The
control bioreactor (CB) and pharmaceutical-added bioreactor (PB) were used to compare
the evolution and development of the systems and their microbial communities.
2.2. Physico-Chemical Determinations
Chemical oxygen demand (COD) and biological oxygen demand (BOD5) were anal-
ysed according to standard methods described by APHA [20]. The COD and BOD5 were
expressed as removal ratio, based on the concentration in the influent and effluent. In addi-
tion, nitrogen ions, NH4+, NO3−, and NO2− were analysed using an ion chromatograph
(Metrohm Ion Chromatograph, AG, Switzerland). The efficiency in terms of nitrogen was
expressed as total nitrogen removal, and the calculation was done using the difference
in concentrations of the nitrogen compounds (NH4+, NO3−, and NO2−), expressed as
mg-N L−1 of the influent and effluent. The settling velocity was measured using a mea-
suring cylinder by recording the falling time of a single granule freely dropped from a
certain height in water, following the protocol described by Laguna et al. [21], and the
mean size of granules was also measured using a scalemeter [22]. Mixed liquor suspended
solids (MLSSs) were measured 3 times a week according to APHA [20]. The dissolved
oxygen and pH in the bioreactors were monitored by a Crison Oximeter and Crison pH
meter, respectively.
2.3. Pharmaceutical Concentration Determination
The samples containing pharmaceutical compounds were analysed. For that, samples
were previously pH adjusted with 0.1 N HCl until they reached pH 4.5. Columns were pre-
conditioned with an elution of 8 mL of methanol and 8 mL of HPLC water, consecutively.
Then, 100 mL of the collected samples were passed through an extraction column in a solid
phase (SPE) Oasis HLB cartridge (200 mg, Milford, CT, USA). Finally, the cartridges were
washed with Milli-Q water (10 mL) and air dried. The extraction was carried out with a
vacuum system.
A sample volume of 10 µL was injected, eluting with a mobile positive ionisation
phase composed of fractions of H2O–formic acid 0.1% (A) and acetonitrile (B), and a mobile
negative ionisation phase composed of the fractions H2O–NH3 0.1% (A) and methanol (B).
The detection system was a Triple Quadruple XEVO-TQ-XS Waters spectrometer (Milford,
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MA, USA). The concentration of the candidate PCs was obtained by interpolation of
standards curves. Pharmaceutical standards were dissolved in acetonitrile.
2.4. Biomass Collection and Nucleic Acid Extraction
With the aim to obtain representative samples of biomass, 100 mL of granules were
taken during the aeration period. Subsequently, sterile saline solution 0.9% was added
to the samples, which were sonicated for 10 min and centrifuged at 8000 rpm at 4 ◦C
for 10 min. Then, supernatants were discarded, and the pellet was preserved at −80 ◦C.
Additionally, RNA Protect reagent (QIAGEN) was added to biological samples and they
were kept at −80 ◦C in order to maintain the quality of the RNA.
Afterwards, DNA extraction was performed on the pellets kept at −80 ◦C using the
FastDNA SPIN Kit for Soil and FastPrep equipment (MP Biomedicals, Solon, OH, USA)
following the protocol given by the manufacturer.
RNA extraction was performed using a FastRNA Blue Kit (MP-Biomedical, USA) fol-
lowing the manufacturer’s protocol. Then, RNA samples were digested using the TURBO
DNA-free Kit (Ambion, Life Technologies Corporation, CA, USA) and the remaining diges-
tates were purified employing the RNeasy Mini Kit (Qiagen, Hamburg, Germany). The
reverse transcription of RNA to cDNA was done using Superscript III Reverse Transcrip-
tase (Invitrogen), following the procedure described by the manufacturer. Finally, DNA
and cDNA extracted libraries were constructed for next-generation sequencing analysis
using specific primers to amplify Bacteria and Archaea domains.
2.5. Massive Parallel Sequencing Procedure
The next-generation sequencing was done using Illumina MiSeq equipment and
Illumina MiSeq Reagent v3, sequencing 300 paired-end nucleotides. Pools of nucleic
acids were amplified twice per sample for each pair of primers and the mix. The pair
of primers Bacteria807F (5′-GGATTAGATACCCBRGTAGTC-3’) and Bacteria1050R (5’-
TAGYTGDCGACRRCCRTGCA) was used for the amplification of the hypervariable region
V5-V6 of 16S rRNA of bacteria [23]. The PCR conditions of the next-generation sequencing
process were the following: 2 min at 95 ◦C; then 30 cycles of: 30 s at 95 ◦C, 30 s at 57 ◦C, and
1 min at 72 ◦C; then 5 min of final elongation at 72 ◦C. The primers used for detection of
the Archaea domain were U519F (5’-CAGYMGCCRCGGKAAHACC-3’) and Arch806R (5’-
GGACTACNSGGGTMTCTAAT-3’) for the amplification of V4 of 16S rRNA of archaea [24].
The PCR conditions of the next-generation sequencing process were the following: 5 min
at 95 ◦C; then 40 cycles of: 30 s at 95 ◦C, 30 s at 56 ◦C, and 1 min at 72 ◦C; then 5 min of
final elongation at 72 ◦C.
2.6. Bioinformatics Pipeline
Data from next-generation sequencing were processed using mothur software
v1.44.3 [25]. Firstly, forward and reverse paired-end reads were merged into contigs
for all raw samples using Needleman alignment conditions, and assuming an ambigu-
ous base in the overlap region when nucleotides in the same position had a difference
in the Phred score lower than 0. The contigs were then subjected to quality trimming to
remove sequences with homopolymers longer than 8 bp, and any ambiguous bases [26].
The remaining contigs were aligned using Needleman conditions through the k-nearest-
neighbour method with k-mer size of 8 bp against the SILVA SEED v123 database. Then,
the contigs that did not align correctly at the forward and reverse positions of the used
primers were removed for both domains. Chimerical contigs were de novo detected using
the VSEARCH algorithm [27]. Then, the remaining contigs were taxonomically classified
against the MiDAS [28] database for bacteria and the MiDAS and SILVA databases for
archaea, using the k-nearest-neighbour algorithm and the k-mer search method with a
k-mer size of 8 bp. The contigs that were not successfully classified at the phylum level in
each of the domains were removed from the analyses. Then, the remaining contigs were
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clustered into OTUs using a distance greedy algorithm with a similarity cutoff of 3% for
bacteria, and 5% for archaea.
2.7. Absolute Quantification of Total and Metabolically Active Microorganisms
The absolute abundances of total and metabolically active communities of bacteria,
archaea, and fungi of the granular sludge were analysed by qPCR and RT-qPCR on key
operational days (days 0, 15, 30, 60, 90, 120, and 180). Quant Studio S3 (Fisher Scientific,
Waltham, MA, USA) equipment was employed to perform the experiments.
The reaction mixture of 25 µL, was composed of: 19.36 µL DEPC sterile water, 2.5 µL
buffer with MgCl2, 0.5 µL dNTPs, 0.15 µL forwards and reverse primers at 10 µmolar,
0.125 µL Taq polymerase, 0.125 µL SYBR Green, and 0.0625 µL BSA (BioLabs). The
primers used are shown in Table S1. For RT-qPCR, the reverse transcription of RNA
to cDNA was performed before qPCR amplification, following the protocol defined by
Maza-Marquez et al. [15]. Standard curves were calculated using ten-fold dilutions of
linearised plasmid-carrying inserts of target genes.
2.8. Statistical Analysis
The diversity analyses were calculated using PAST v3.4. software. The α-diversity was
evaluated by means of Simpson and Shannon–Wiener indices. The β-diversity, analysed to
compare the differences between pairs of samples, was assessed by the Whittaker index.
The similarity percentage analysis (SIMPER) was calculated to observe the contribu-
tion of dominant OTUs to dissimilarity between pairs of samples of the control reactor and
amended with the PC reactor. The OTU tables, calculated by a centred logarithm for the
Bacteria domain, were used for calculation of SIMPER through the Bray–Curtis similarity
using PAST software v3.4.
Principal coordinates analysis (PCoA) weighted by Bray–Curtis, was calculated
through the centred logarithm OTU tables, and 999 bootstraps, in order to build the
plot by PAST software v3.4.
2.9. Multivariate Redundancy Analysis and PERMANOVA
Multivariate redundancy analyses were conducted to detect the linkage between
bacterial OTUs, biological samples over operational time, physico-chemical parameters
(removal of COD, BOD, TN, settling velocity, granule size, MLSS), and the number of
copies of cDNA and DNA target genes and the relationships between domains. The RDA
was calculated with OTU tables corrected for zero values, centred log-ratio transformed
and computed by 499 unconstrained Monte Carlo simulations under a full permutation
model and run using the software CANOCO 4.5. The relative abundance of the bacterial
phylotypes with at least ≥2.0% in biological samples on operational days 0, 15, 30, 60, 90,
120, and 180 were taken for the calculation procedure.
The PERMANOVA analyses were calculated to indicate the effect of pharmaceutical
compounds on the most abundant bacteria (total and active), the copy number of target
genes, and the physico-chemical parameters of the granular sludge systems. The analysis
was computed using PASTv3 calculated under 9999 permutations of the Bray–Curtis
algorithm [22].
3. Results and Discussion
3.1. Granular Development and Biomass Characteristics
The bioreactors were inoculated with mature granules from a sequential batch reactor
operated under a steady-state period at 15 ± 1.2 ◦C. The average size of granules used
for the inoculum was around 0.70 mm. During the first twenty days of operation, both
granular biomasses showed a reduction in diameter, with values of 0.57 mm and 0.60 mm
for the CB and PB, respectively (Figure 1A). Then, the trend altered from operational day
50, especially in the CB, because the mean size of the granules enlarged until they reached
average values ranging from 1.00 to 1.20 mm. The size of granular particles cultivated
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in the CB remained stable from operational day 110. The largest granules were detected
in this reactor, even larger than the granules used for the inoculum. Thus, these results
demonstrate the essential role of the design parameters of the bioreactor (for instance
height–diameter ratio) and influent characterisation for the granule conformation, agreeing
with Awang et al. [29].
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Figure 1. Mean size (A) and settling velocity (B) of granular biomass grown in CB (green triangle)
and PB (blue diamond).
In the PB, the granular size d cre sed during the first month of operation, from
0.70 mm to 0.55 mm, possibly caused by the effect of pharmaceuticals on the microbial
population. Then, there was a weakly rising trend from operational day 50 to operational
day 140. After this period, the granules were very stable and dense, with average values
between 0.80 mm and 1.00 mm. Likewise, granules of the PB exhibited a compact structure
with a spherical outer shape. Wan et al. [30] reported an increase in EPS production in the
presence of pharmaceutical compounds, suggesting a stronger aggregation of cells.
In general, the dimensions of the granular biomass were higher in the CB, while those
in the PB had a small r size, albeit with a ore compact and dense spect (Figur 1A).
The granular properties were also measured by the settling ability of the biomass
(Figure 1B). This parameter showed an opposite trend in comparison with granular size,
because the smaller granules settled faster. Consequently, the biomass belonging to the PB
settled faster in general terms, a fact previously described by Wan et al. [30]. These results
suggest that the pressure exerted by the chemical compounds on the biomass makes the
granules denser, so they can decant faster, improving the settling rate and their physical
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strength. On the other hand, the granules from the CB showed a larger size but a slower
settling velocity, around 10 m h−1 slower than the granules in the PB.
The mean size and settling velocity analyses showed that there was a negative corre-
lation between both parameters. The fastest granules were found in the PC and reached
average velocities that exceeded 100 m h−1. Biomass from the CB had a settling velocity
ranging from 65 to 82 m h−1.
The seed granular sludge used as an inoculum in the reactors had an MLSS concen-
tration of 1.6 g L−1. In the first few days, the MLSSs were reduced from 1.6 to 0.26 g L−1
due to the effluent withdrawal in the reactors (Figure 2). This pattern is widely observed
during the setup of AGS systems and is caused by microbial selection by the operational
conditions [31]. After 20 days of operation, the MLSSs increased sharply from 0.9 g L−1 to
2.2 g L−1 in the PB reactor, while that in the control bioreactor reached 3.1 g L−1. There-
fore, MLSSs experienced a strong washout after 25 days of operation, as described by
Othman et al. [32], presumably because of the transition from one bioreactor to the other,
design bioreactor. The lower MLSS concentration in the PB could be caused by the pres-
ence of drugs in the influent water, according to findings by Wan et al. [30], in which the
MLSS concentration was slightly lower in the reactor amended with antibiotics than in the
control reactor.
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3.2. Physico-Chemical Removal Efficiencies
The physico-chemical performance ratio was evaluated in the CB and PB. At the
beginning of experimentation, COD removal values showed a decreasing trend, while they
seemed higher from operational day 20 onwards, reaching a steady-state scenario. This
fact was linked with the strong depletion of MLSSs in the system due to the selection of
floc-forming microorganisms. The ifferences between the p armaceutical and control
rea tor were more strikingly arked until operational day 100, because in this period the
CB reactor was able to remove 95% of COD, while the PB removal efficiency was in the
range of 70 to 80%. From operational day 100, a stable scenario was achieved for both
reactors regardless of the pharmaceutical compounds added, the highest efficiency being
close to the range of 93 to 98% (Figure 3A).
The BOD5 removal followed a similar trend to the COD removal efficiency (Figure 3B).
During the first month, BOD5 concentration in the effluent was around 100 mgO2 L−1
in the PB. Then, the removal ratio steeply increased, with values in the effluent of less
than 15 mgO2 L−1 in both bioreactors. Despite both reactors achieving very good effluent
quality, the PB generated an effluent with s ightly higher BOD5 conc ntra ions.
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The nitrogen removal trend was significantly different amongst the reactors (Figure 3C).
The control reactor remained stable from the beginning to the end of experimentation,
with a performance displaying values always higher than 80% of total nitrogen, except for
occasional days with a removal ratio between 60 and 70%. These results can be contrasted
with the values obtained from the nitrogen analysis of the PB reactor, which showed
a robust effect in the performance related to total nitrogen removed, due to low rates
of nitrogen removal within the system. The average values of the removal ratio were
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lower than 50% until operational day 110. Some studies have reported the effects that
pharmaceuticals had on ammonia oxidation as well as in denitrification processes [26].
Thus, it was reasonable to speculate that not only nitrifying bacteria, but also some other
microbes involved in parallel metabolic processes, would be affected. Then, the tendency
of nitrogen removal grew progressively until reaching stable values, higher than 70%, at
operational day 140.
The results of total nitrogen removal showed a clear effect of pharmaceutical com-
pounds on the nitrogen cycle carried out by the granular biomass, because these chemicals
were the only difference between both reactors. In this sense, it is possible to conclude
that the required time to achieve good removal ratios in a reactor treating pharmaceutical
compounds is longer, but after a period of acclimatisation, the ratios are similar with respect
to a non-pharmaceutical scenario.
In Figure S2, it is possible to observe in more detail the differences amongst reactors
in the ammonium oxidation and denitrification processes. The CB was very stable; the
ammonium oxidation ratio was excellent from operational day 80 to the end of the exper-
iment with practically all the ammonium in the effluent oxidised to nitrite. Nitrite and
nitrate conversion was effective, with nitrate values lower than 8.0 mg L−1 and nitrite
concentrations lower than 4 mg L−1. On the contrary, the ammonium oxidation was not so
good in the PB, although the trend was positive. Therefore, the denitrification process was
not successful until operational day 120, from which values of 20 mg L−1 were reached.
3.3. Pharmaceutical Compound Analysis
Four drugs were chosen as target pollutants, namely: diclofenac, naproxen, carba-
mazepine, and trimethoprim. The profile of pharmaceutical compound analysis is shown
in Figure 4, reproducing the influent and effluent concentrations of the AGS system. For
each contaminant, the influent concentration was 25 µM.
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The results showed that the PB had a better removal effect on two drugs, trimethoprim
and diclofenac, while the removed concentration of naproxen and carbamazepine was
lower. In general terms, at the beginning of experimentation, the effluent concentration was
very low, removing 30 to 70% of the influent concentration. This fact could be explained
by the adsorption in the external layers of the AGS caused by the superficial charges of
EPS [33,34]. However, over operational time, the concentration measured in the effluent
showed lower values of biodegradation, biotransformation, and/or bioadsorption by the
granular sludge. Therefore, a gradual decline of pharmaceutical removal was observed,
probably related to the decrease in AGS adsorption capacity, especially for carbamazepine
and naproxen. This hypothesis has been described previously by several authors research-
ing AGS technology for the treatment of pharmaceutical compounds [34,35]. Moreover,
other authors presented the AGS system as more able to degrade some pharmaceuticals
such as sulfametazol, while other pharmaceuticals, such as roxithromycin, are removed
from the effluent by adsorption mechanisms of AGS biomass [36].
As was mentioned before, carbamazepine was the most recalcitrant compound in
the effluent despite the high capacity of AGS to biotransform, biodegrade, and/or bioad-
sorb pharmaceuticals [34,37]. This effect was previously described by Carballa et al. [38],
who found carbamazepine to be highly resistant to degradation, while diclofenac showed
moderate to high removal in wastewater treatment plants. Likewise, Blunt et al. [39]
reported that trimethoprim has been proven to be highly resistant to degradation through
wastewater treatment processes. Subsequently, this fact pointed out and made stronger the
hypothesis about the bioadsorption ability of AGS to capture trimethoprim. Moreover, Bar-
ros et al. [40] demonstrated great variations of granular biomass to remove trimethoprim
in wastewater, varying from 0 to 80%. The results of this experimentation showed that
naproxen was poorly removed, especially at the end of the experiment, from operational
day 120 to 180, possibly due to the saturation of the biomass by the different pharmaceuti-
cals existing in raw water. Other authors have highlighted a better removal capacity for
anti-inflammatory drugs, such as diclofenac or naproxen, than antibiotics such as trimetho-
prim, or antiepileptic drugs such as carbamazepine [41]. It is important to mention that
the granular conformation was not greatly affected by the presence of pharmaceuticals,
although some significant differences were found in comparison with the CB, mainly in
the size and the settling ability. Thus, it was noted that the presence of pharmaceuticals
made the granules more compact and denser than without the presence of drugs [30].
3.4. Abundance of Total and Metabolically Active Populations of Bacteria, Archaea, and Fungi in
Aerobic Granular Sludge Reactor
To quantify the target genes in the granules, RT-qPCR and qPCR were conducted
(Figure 5). The absolute abundance of total bacteria increased strongly between operational
day 0 and day 15. Then, these genes remained tangibly stable from operational day 15 for
both bioreactors, with an order of magnitude of around 12. For target genes of total archaea,
the quantification showed slight and progressively decreasing values over the operational
time, because at the beginning of the experiment, they were reported to be close to an order
of magnitude of five, while those at operational day 180 had orders of magnitude of 4 and
2, for CB and PB, respectively. Therefore, total archaea genes were considerably affected
by the presence of pharmaceutical compounds, possibly because they had competitive
disadvantages against bacterial or fungal microorganisms. Hence, archaea suffered a
decrease during the operation, a fact that could be corroborated with quantification of the
activity in Figure 5D, since archaea activity disappeared from operational day 30. On the
contrary, Figure 5C shows a loss of archaeal activity but not the complete disappearance of
this domain, a fact observed without the presence of PCs. The results reflect the importance
of evaluating the total and active microorganisms, because they provide an overview of
the abundance and activity in which the target microorganisms are involved in pollution
degradation, as Maza-Marquez et al. [16] reported.
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The trend of fungi is very variable, as Muñoz-Palazón et al. [22] and Maza-Marquez
et al. [15] have reported, because it depends closely on the environmental conditions and
operational parameters. In this sense, the total and active quantification provided evidence
about the fungal capacity to counteract toxic compounds [3]. In this way, there was a
markedly larger number of copies of active fungal organisms than total fungi of the order
of one or two magnitudes, regardless of the reactor. Therefore, the fungal copies seem to
have the capacity to resist pharmaceuticals because the number of copies was larger in the
PB (Figure 5B,D). In general, the number of copies of 18S rRNA and rRNA genes weakly
increased over the experimental time until granules reached two orders of magnitude of
fungi per gram of biomass.
3.5. Aerobic Granular Sludge Prokaryotic Composition of Total and Active Population Analysed by
Massive Parallel Sequencing
3.5.1. Dynamics of Total and Active Metabolically Bacterial Communities
The bacterial co munity established within the granules pl ys a crucial role in
the physico-chemical performance and granular conf rmation, which could be affect d
by the presence of emergent contaminants, such as pharmaceuticals, as reported by
Amorin et al. [35]. Obviously, the bacterial comm nities of granules used as inocula
were very similar for both reactors at operational day 1. The most dominant OTUs were
taxonomically affiliated to the Co amonadaceae family and the Dokdonella genus. Several
phylotypes belonging to the Comamonadaceae family have been commonly reported in
aerobic granular sludge (Figure 6). The family is able to carry out metabolisms involved in
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the nitrogen cycle and organic matter degradation [17]. Nevertheless, Dokdonella is mostly
described in aerobic granular sludge systems operated at low temperature [17,42]. The
genus Dokdonella contains several known species and some of them have physiological
characteristics that reduce nitrate in aerobic conditions [43]. Several technologies, such
as activated sludge, have shown the Dokdonella genus and the Comamonadaceae family
to be among microorganisms involved in the degradation of nitrate-containing organic
pollutants [17,43]
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Figure 6. Distribution of the microbial com unity of DN (>1.50 ) in the reactors CB (control) and PB (supplemented
with pharmaceuticals).
The total bacterial community in the control reactor showed a decline in relative
abundance of dominant OTUs from the inoculum. The decrease could be caused by
changes in operational conditions, and especially in the reactor configuration and design, in
comparison with the granules used as an inoculum processed by the reactor. Consequently,
other phylotypes proliferated from operational day 15 to 30, with some OTUs belonging
to the Cytophagaceae family and the Brevundimonas genus being especially interesting. The
number of representative OTUs with high relative abundance changed over the operational
period, although some of them, such as the Cytophagaceae, Dokdonella, Brevundimonas
and Comamonadaceae families, remained stable. At days 60 and 90, together with those
previously described, the most representative bacteria were taxonomically classified as
belonging to the Saccharibacteria phylum. At the last stage of operation, the bacterial
community study of the CB showed that the community remained in equilibrium in
relation to previous days, demonstrating the stability of the bacterial community.
On the other hand, the reactor amended with pharmaceuticals reflected a considerable
influence on the bacterial community in comparison with populations of the CB. Then,
Otu001 was present during the whole experiment, although its relative abundance was
lower over time. The major changes in the population were reported from operational
day 30, possible due to the acclimatisation of microorganisms to the presence of toxic
compounds. In this sense, the diversification of phylotypes was tangible because several
phylotypes acquired relevance in the population, such as Otu009, Otu010, Otu017, and
out019, OTUs taxonomically affiliated to Pseudomonas, Gemmobacter, and Flavobacterium.
Certainly, the majority of them have been reported in biological technologies for treating
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wastewater containing pharmaceuticals [35,40]. The Flavobacterium genus could play an
essential role in the treatment of drugs because it possesses antibiotic resistance genes [39].
In fact, Tiwari et al. [44] reported Flavobacterium growth in the presence of pharmaceuticals.
Moreover, Flavobacterium was reported to promote the production of cyclic-diguanylate,
which encourages EPS production and, in that way, protects microorganisms within gran-
ules against toxic compounds [35], while this production stimulates the compaction and
aggregation of cells [11]. In the steady state, other OTUs belonging to the genera previously
described proliferated. At the end, the most dominant bacteria were Otu007, belonging to
the Comamonadaceae family, as well as Hyphomicrobium which had significant representation
in the population, with more than 16.00% of relative abundance. Hyphomicrobium has been
reported as the most abundant phylotype in an aerobic granular sludge system treating
pharmaceutical compounds [36].
The active bacterial population followed a similar dynamic for both the CB and PB
(Figure 7). Undoubtedly, the trend was sharper, meaning that the relative abundance was
higher for the most representative phylotypes. The CB showed high relative abundance of
some newly described OTUs, especially in the case of Leadbetterella and Xanthobacteraceae,
as well as other phylotypes belonging to Saccharibacteria and Brevundimonas. A similar
trend was observed for the PB, because the representative OTUs acquired a higher relative
abundance in the dynamic populations.
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Figure 7. Distribution of the microbial community of RNA (>1.50%) in the reactors CB (control) and PB (supplemented with
pharmaceuticals).
3.5.2. Archaeal Population
The archaeal population was studied over operational time, however, the results
obtained by the taxonomic affiliation with two different databases (full SILVA and MiDAS)
did not provide information about the taxonomy of them. The lack of knowledge about the
archaeal community should promote the development of deeper studies about this domain
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and its ecological role in biological wastewater, which has been reported to have essential
roles in the natural environment and in engineered systems [17].
Some archaea found at a low relative abundance were Methanoperedens and Methanobre-
vibacter, as well as some OTUs belonging to Euryarchaeota.
3.6. Alpha and Beta Diversity Analyses
The values of the Simpson and Shannon–Wiener indices for bacterial populations
from the inoculum to the end of experimentation, with the aim to evaluate the diversity
and evenness of the biological samples, are shown in Table S2. The results of DNA analyses
reflected analogous values for both bioreactors over the operational time. On the contrary,
the Shannon–Wiener results demonstrated a rise in diversity and evenness in the CB from
operational day 0 to day 15, which remained stable until the end of operation, while weak
oscillations were observed in the PB. The analysis could be completed with community
studies because a lower evenness was observed in the PB. In this way, during the first
3 months of operation, the PB showed lower evenness and diversity indices in the bacterial
communities. Nevertheless, after this period, they increased notably, achieving similar
values as in the control bioreactor. This trend could be explained by the acclimatisation of
bacterial communities to the presence of toxic compounds in the influent, as well as the
biodegradation, biotransformation, and/or bioadsorption of pharmaceuticals.
The β-diversity analysis is shown in Figure S3 for total bacteria (A) and metabolically
active bacterial populations (B). The Whittaker index for DNA and RNA showed a high
similitude of the CB at day 180, with all samples belonging to this reactor despite the
operational time. However, greater dissimilarities were found in the progressive biological
samples of the PB over the experimental time, showing changes produced by the opera-
tional conditions and factors, such as the pharmaceutical compounds. In fact, the most
pronounced differences were observed in the pairs of samples belonging to days 60, 90,
and 120, when the system started to achieve physico-chemical stability.
Likewise, a striking pattern between reactors was detected, with samples at day 180 of
the CB showing high similarities with all samples of the PB reactor. This fact could mean
that generic phylotypes that comprised the mature granules are extremely stable.
3.7. Similarity Analysis of Bacterial Samples
The SIMPER analysis showed the contribution to dissimilarities between dominant
and representative phylotypes for both reactors, indicating the relative impact of each
OTU (Figure S4). The number of total OTUs that contributed more than 1.50% to RNA
or DNA samples totaled 19. The general trend showed that the contributions greater in
samples of metabolically active genes than in the total 16S rRNA genes. One representation
of the trend highlighted Otu003, which showed the highest contribution to disparities
between reactors, with 6.00% and 8.00% of relative abundance for DNA and RNA samples,
respectively. These outcomes suggested that despite the existence of specialised phylo-
types, metabolically active microorganisms modified the relationships in the communities.
Therefore, this hypothesis was reinforced by several OTUs, which were found to have a
great contribution to dissimilarities in samples of 16S rDNA, but they were even more
marked in the metabolically active populations. Otu003 belonged to the Comamonadaceae
family and was one of the most representative phylotypes in both systems, originating
from the biomass used as an inoculum, whereas, during the operation, Otu003 was more
persistent in the PB.
Additional OTUs that contributed to disparities with more than 5.00% of relative
abundance were Otu001, Otu002, and Otu004, taxonomically affiliated to the Comamon-
adaceae family, the Dokdonella genus, and the Cytophagaceae family, respectively. These OTUs
showed opposite trends for both reactors, as corroborated by the community studies. The
results showed Cytophagaceae as exclusively outstanding in the CB, and their metabolic
activity consolidated pronounced differences (>7.00%) related to the PB, which did not
show the presence of Otu004.
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Otu006, Otu007, Otu008, Otu009, Otu010, and Otu17 contributed to dissimilarities
between the CB and PB. Of special interest were Otu010 and Otu17, belonging to the
Gemmobacter and Pseudomonas genera, because they contributed to differences at 4.00%.
These phylotypes were dominant in the PB over the operational time under drug loads.
On one hand, principal coordinate analysis (PCoA) for 16S rRNA gene samples re-
vealed a strong clustering of all samples of the CB, and the samples of the first 3 months of
operation of the PB, while samples of mature granules of the PB reflected more distance
between themselves (Figure S5A). On the other hand, the PCoA plot shown in Figure
S5B reflects a larger spatial distribution of bacterial 16S rRNA samples than 16S rRNA
gene samples. One big group was clustered with the initial samples of both AGS reactors;
separately, a second aggrupation was found at day 90 and day 60 of the CB, where some
phylotypes such as Gemmobacter and Pseudomonas notably proliferated. Finally, a third
group was composed of samples at day 60 and day 180 of the PB. The results demon-
strated that drugs affected the total population and, more mildly, the metabolically active
bacterial population.
3.8. Multivariate Redundancy and PERMANOVA Analyses
The RDA shown in Figure 8A reflects the correlations of the most dominant OTUs
with >2.00% of relative abundance with the physico-chemical removal performance and
granular conformation in the CB reactor. The total nitrogen removal was linked with
Otu004 and Otu038 which are taxonomically affiliated to the Cytophagaceae and Rhodobac-
teriaceae families. Rhodobacteraceae is an enormous and complex family whose members
have been reported as aquatic bacteria frequently thriving in marine environments and
wastewater [45]. Enrichment of this family in biological reactors for nitrogen removal has
been previously reported [46], as well as some genera of this family, such as Zooglea, play-
ing a crucial role in the conformation of granular sludge [17]. Likewise, the Cytophagaceae
family is closely associated with nitrogen fixation metabolism as nitrogen-incorporating
bacteria in several environments [47]. The COD removal ratio, MLSSs, and the granular
size were positively correlated with several OTUs, and among them the most represen-
tatives in the CB were Hypomicrobium, Brevundimonas, Flavobacterium, Xanthomonadaceae,
and Dysgonomonas. The majority of them can degrade organic matter and also carry out
other complementary metabolisms, such as heterotrophic denitrification in the case of Hy-
pomicrobium [48]. Furthermore, they produce extracellular polymeric substances, assisting
cell aggregation [11]. The settling velocity and BOD5 degradation were strongly correlated
with the Leadbetterella genus that has been suggested as a group of functional syntrophic
organic compound-degrading bacteria [49].
The RDA displayed in Figure 8B indicates the pronounced disparities found in the
active population and their relationships with the performance in the CB. In this sense,
the total nitrogen removal ratio was strongly linked with Otu002 and Otu005, affiliated
to Dokdonella and Brevundimonas, respectively, which are reported as nitrogen removal
bacteria in wastewater environments [50]. For instance, both genera reduce nitrate in
aerobic conditions [51,52]. On the other hand, the organic matter removal (COD and
BOD5 removal ratio), as well as biomass properties (MLSSs, size and settling ability), were
positively correlated between them. This cluster was interconnected with Saccharibacteria,
Proteiniphilum, Leadbetterella, and Arzoarcus genera. Certainly, some of these taxa are unusual
in wastewater, but they have been reported previously [53].
In order to compare the total and active population linked with removal performance
and granular properties in a bioreactor amended with PCs, multivariate redundancy
analysis was calculated, which is shown in Figure 8D,E. Figure 8D shows the total bacterial
population and the correlation with the physico-chemical determinations. The analysis
reveals the linkage of biological samples at days 90, 120, and 180, positively correlated
with higher removal ratios, as well as larger granular size and biomass concentration. The
number of OTUs positively correlated to this parameter is small, so the majority of them
are negatively correlated with high performance, such as Otu001, Otu002, Otu003, Otu005,
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and Otu009. These results show that the initial population from the inoculum is not able
to acclimatise to the presence of a large load of pharmaceuticals, and thus encourages the
proliferation of bacteria able to resist the presence of these compounds. Consequently, the
OTUs positively correlated with high removal ratios and granular stability were Otu007,
Otu011, Otu012, Otu016, Otu041, Otu045, Out068, and Otu069, among others. A lot of
them proliferated during the operation under pharmaceuticals, such as Corynebacteriaceae
or Comamonadaceae, which attained a very high relative abundance at operational days 120
and 180. These genera are common in aerobic granular sludge systems [12,17,21].
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In the same way, the RDA shown in Figure 8E follows a similar pattern, with analogous
correlations with the RDA of total bacterial genes. In this sense, these results meant that in
the presence of toxics, the total and metabolically active population are more closely linked,
and thus they are more representative, and they are more deeply corroborated. Validating
this fact, Otu041, Otu045, and Otu069 were tightly related to granular size, settling ability,
and MLSSs. In the same direction, Otu001, Otu002, and Otu003 were strong and negatively
correlated with the right operation and performance of the system.
The RDA associated the copy number of total and active target genes with the pollution
degradation in the CB (Figure 8C) and PB (Figure 8F). For the CB, a correlation was
found for the copy number of total and metabolically active archaeal 16S RNA genes and
organic matter, nitrogen removal, and the granular properties. On the contrary, a strong
and positive correlation was found for 18S rRNA gene fungal copies with COD and TN
removal, as well as with MLSS concentration and the decanting velocity, especially close to
the biological sample at day 180.
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The reactor amended with pharmaceutical compounds showed a different pattern
(Figure 8F), because, in this case, a negative correlation was detected for the high physico-
chemical yield and granular stability with the copy number of total and active archaea.
Thus, the outcomes of both RDA analyses were either negative or neutral in the presence of
archaeal microorganisms, with a good performance in this kind of technology, regardless
of influent characterisation. This fact could be caused by the competitive disadvantage of
this domain against the high abundance of bacterial or fungal organisms.
In the PB reactor, the copies of active bacterial 16S rRNA were closely linked with the
granular properties (MLSSs, settling velocity, and granular size), while the total number of
bacteria was not strictly positively correlated. Likewise, the number of total and metabol-
ically active fungal copies was positively correlated with the settling ability of granules.
Some authors have described the role that fungi play in the initial microbial aggregation
and optimum granular conformation, because they act as union bridges between cells
which contribute to compactness [17,21].
PERMANOVA analysis allowed us to corroborate the statistically significant effect of
the treatment of large loads of pharmaceutical compounds using aerobic granular sludge
(Table S3). In this way, the PERMANOVA analysis calculated the influence of the drug
mixture on metabolically active and total bacteria (the most representative ones). The
values obtained marked the significant effect that pharmaceuticals have on Otu004 and
Otu006 (ρ < 0.005), for both active and total bacteria. Additionally, in terms of activity,
Otu008, which was affiliated with Saccharibacteria and only detected in the CB, was affected
by pharmaceuticals.
On the other hand, all the physico-chemical determinations, except MLSSs, were
significantly affected when treating pharmaceutical compounds. These results were cor-
roborated in the chemical analysis and granular properties, as reflected in Section 3.1. and
Section 3.2. This pattern was more strongly perceived during the first 100 days.
The absolute quantification of target genes was not affected by the pharmaceutical
compounds, except for the active fungi, which increased significantly in terms of the
number of copies in the PB. This fact could be supported by the competitive advantage
that fungi have over bacteria in the presence of antibiotics.
4. Conclusions
Aerobic granular sludge systems were operated for the treatment of wastewater with
a large load of mixed pharmaceutical compounds. The drug removal efficiency was espe-
cially marked for the anti-inflammatory diclofenac and the antibiotic trimethoprim. During
the initial period of treatment, the granules showed a strong bioadsorption capacity. The
granular conformation was not affected by the presence of pharmaceutical compounds
due to high resistance capacity of the granules, although they were statistically significant
in comparison with the control reactor in terms of settling velocity and size. The settling
ability was improved by the presence of pharmaceutical compounds. High organic matter
and nitrogen removal levels were reached after a period of acclimatisation, when the most
resistant microorganisms, such as the genus Hyphomicrobium and Comamonadaceae family,
played an important role in the system. The differences among bacterial communities
were corroborated by SIMPER, PERMANOVA, PCoA, and β-diversity. The metabolically
active communities in the bioreactor control and the bioreactor supplemented with phar-
maceuticals evolved divergently. In the control reactor, the relative abundance showed
similarity with the results of the total bacterial population, while the reactor amended with
drugs showed a notable increase in relative abundance with respect to the development
of the total community. Despite the high level of representation of some phylotypes in
the DNA studies, their presence is not tightly correlated with the role microorganisms
play. The qPCR and RT-qPCR showed the notable contribution of fungal organisms in the
granular sludge technology with pharmaceutical compounds. Additionally, the absolute
quantification confirmed the disadvantageous position of archaea in environments with
high toxic loadings.
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Thus, our research supplies essential information for the implementation of AGS
systems at full scale to treat wastewater with high pharmaceutical compound loadings
for urban or industrial wastewater. In this sense, we have provided a detailed study to
demonstrate the effect of toxic compounds contained in wastewater on aerobic granular
sludge systems based on chemical performance and the physical granular morphology, as
well as the total and metabolically active microbial community within the granules.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/toxics9050093/s1, Figure S1: Configuration and design of AGS systems, Figure S2: Ammo-
nium, nitrate and nitrite concentration in the effluent in control bioreactor (A) and pharmaceutical
bioreactor (B), Figure S3: β-diversity analyses by Whittaker indices (A: DNA pair of samples; B: RNA
pair of samples), Figure S4: SIMPER analysis of the most contribute OTU to dissimilarity between
control reactor and reactor amended with pharmaceutical compounds, Figure S5: Principal coordi-
nate analysis of total community (A); and metabolically active community (B) for control bioreactor
(red) and amended bioreactor (purple), Table S1: (A) Primers used for quantification of total Bacteria,
total Archaea, total Fungi throught RT-qPCR and qPCR. (B) qPCR conditions for the amplification
and quantification of interest genes, Table S2: α-diversity analysis calculated thought, Shannon
Wienner and Simpson indices for RNA and DNA biological samples for both reactors, Table S3: One
way PERMANOVA analysis among control and pharmaceutical bioreactors.
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